Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

PCR primer sequences of genes used in this study.

More »

Table 1 Expand

Fig 1.

Chromatograph profiles.

(A) Monosaccharide composition of standard sample; peaks 1–10: fucose, rhamnose, arabinose, galactose, glucose, xylose, mannose, fructose, glucuronic acid, galacturonic acid. (B) Monosaccharide composition of C. cicadae extract crude polysaccharides; peaks 1–3: galactose, glucose, mannose.

More »

Fig 1 Expand

Table 2.

Average molecular weights of three C. cicadae extract crude polysaccharide fractions.

More »

Table 2 Expand

Fig 2.

Chromatograph profile of C. cicadae extract alditols and saccharides.

More »

Fig 2 Expand

Fig 3.

Chromatography profile of nucleoside standards (black signal) and C. cicadae extract (CCE; blue signal); peaks 1–12: Cytosine, uracil, cytidine, hypoxanthine, uridine, thymine, adenine, inosine, guanosine, thymidine, adenosine, cordycepin.

More »

Fig 3 Expand

Fig 4.

Antioxidant activities of C. cicadae extract estimated by different methods.

(A) ABTS [2,2-azino-bis (3-ethylbenzothiazo-line-6-sulphonic acid)] radical scavenging; (B) DPPH (2,2-diphenyl-1-picrylhydrazil) radical scavenging assay; (C) ferric reducing antioxidant power assay.

More »

Fig 4 Expand

Fig 5.

Human skin fibroblasts were cultured with C. cicadae extract (0, 5, 10, 50, 100, 500 and 1000 μg/mL) for 24 h, and cell viability was measured by MTT assay (n = 3), * P < 0.05, ** P < 0.01 compared with the control group.

More »

Fig 5 Expand

Fig 6.

The content of hyaluronan of fibroblasts in the CCE 50, 100 μg/mL treated and non-treatment group.

* P < 0.05, ** P < 0.01 compared with the control group.

More »

Fig 6 Expand

Fig 7.

Immunofluorescence staining of fibroblast nuclei (blue) and hyaluronan (green) at 10× magnification.

Fibroblasts were non-treated (A), treated with C. cicadae extract at concentrations of 50 μg/mL (B) and 100 μg/mL (C), treated without the antibody 488 as negative control (D).

More »

Fig 7 Expand

Fig 8.

Gene ontology analysis of differentially expressed genes between C. cicadae extract-treated (50 μg/mL) and non-treated fibroblasts.

More »

Fig 8 Expand

Fig 9.

Distribution of enriched KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways of differentially expressed genes between C. cicadae extract-treated (50 μg/mL) and non-treated fibroblasts.

More »

Fig 9 Expand

Table 3.

Differentially expressed genes related to hyaluronan synthesis between C. cicadae extract-treated and non-treated fibroblasts.

More »

Table 3 Expand

Fig 10.

RT-qPCR expression levels of five hyaluronan-related genes in C. cicadae extract (CCE)-treated and non-treated (NT) fibroblasts, * P < 0.05, ** P < 0.01 compared with the control group.

More »

Fig 10 Expand